Intractable & Rare Diseases Research

Scope & Guideline

Bridging Gaps in Rare Disease Knowledge.

Introduction

Delve into the academic richness of Intractable & Rare Diseases Research with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2186-3644
PublisherINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
Support Open AccessNo
CountryJapan
TypeJournal
Convergefrom 2012 to 2024
AbbreviationINTRACTABLE RARE DIS / INTRACTABLE RARE DIS. RES.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT, TOKYO 00000, JAPAN

Aims and Scopes

The journal 'Intractable & Rare Diseases Research' focuses on the complex landscape of rare and intractable diseases, providing a platform for innovative research that addresses both clinical and scientific challenges. Its aim is to enhance understanding, diagnosis, and treatment of these conditions through rigorous analysis and interdisciplinary collaboration.
  1. Epidemiology of Rare Diseases:
    The journal emphasizes the importance of understanding the prevalence and distribution of rare diseases, including comprehensive epidemiological studies that highlight the burden these conditions place on healthcare systems.
  2. Genetic and Molecular Research:
    Research on the genetic underpinnings of rare diseases is a core focus, including studies on genetic mutations, biomarkers, and the development of genetic diagnostics that facilitate better patient management.
  3. Clinical Management and Treatment Approaches:
    Papers often explore novel treatment strategies and management protocols for rare diseases, including case studies, clinical trials, and reviews that contribute to improved patient outcomes.
  4. Patient-Centered Research:
    The journal prioritizes research that includes patient perspectives, quality of life assessments, and psychosocial impacts of living with rare diseases, fostering a holistic understanding of these conditions.
  5. Innovative Technologies in Rare Disease Research:
    There is a consistent interest in the application of advanced technologies, such as artificial intelligence and metabolomics, to improve diagnostics, treatment efficacy, and understanding of disease mechanisms.
The journal has identified and embraced several emerging themes that reflect the evolving landscape of rare disease research. These trends highlight areas of growing importance and potential impact on clinical practice and patient care.
  1. Integration of Artificial Intelligence in Rare Disease Research:
    A significant trend is the increasing incorporation of artificial intelligence technologies in diagnosing and managing rare diseases, showcasing innovative methodologies that enhance precision medicine.
  2. Focus on Quality of Life and Patient Experiences:
    There is a growing emphasis on understanding the quality of life and psychological impacts of rare diseases, indicating a shift towards more holistic patient-centered research.
  3. Innovations in Genetic Diagnostics:
    Emerging themes include advances in genetic diagnostics, such as whole-exome sequencing and next-generation sequencing technologies, which are revolutionizing the understanding and management of genetic disorders.
  4. Interdisciplinary Collaborations:
    Research that involves interdisciplinary approaches, combining insights from genetics, epidemiology, and clinical practice, is increasingly prominent, reflecting the complex nature of rare diseases.
  5. Emerging Treatments and Therapeutics:
    There is a rising interest in novel therapeutic approaches, including gene therapies and personalized medicine strategies, that promise to address unmet needs in rare disease treatment.

Declining or Waning

While the journal has seen a rich variety of themes over the years, certain areas appear to be declining in prominence. This may reflect shifts in research focus or advancements in knowledge and technology that have rendered some topics less critical.
  1. General Reviews of Rare Diseases:
    There has been a noticeable decrease in broader reviews of rare diseases as more targeted, specific studies emerge. The focus is shifting towards in-depth analyses rather than general overviews.
  2. Historical Perspectives:
    Papers that provide historical context or retrospective analyses of rare diseases are appearing less frequently, suggesting a trend towards more forward-looking research that emphasizes current issues and future directions.
  3. Basic Science without Clinical Relevance:
    Research that delves into basic science aspects of rare diseases without a clear clinical application or relevance is becoming less common, as the journal increasingly favors studies that bridge the gap between laboratory findings and clinical practice.
  4. Epidemiological Studies in Developed Regions:
    There appears to be a waning interest in epidemiological studies focused solely on developed countries, likely as the journal aims to highlight the global burden of rare diseases, particularly in under-researched regions.

Similar Journals

Annals of Medicine and Surgery

Transforming Healthcare with Evidence-Based Studies
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2049-0801Frequency: 12 issues/year

Annals of Medicine and Surgery is a reputable multidisciplinary journal published by Lippincott Williams & Wilkins, focusing on a broad range of topics pertinent to both medicine and surgery. With an ISSN of 2049-0801, this journal aims to disseminate innovative research findings and clinical studies that contribute to the advancement of medical and surgical practices. Since its inception in 2012, it has established itself within the academic community, achieving a Q3 ranking in both the Medicine (miscellaneous) and Surgery categories for 2022. Despite its coverage being discontinued in Scopus, the journal continues to receive attention, ranked in the 45th percentile for its fields, illustrating its growing influence. Researchers, healthcare professionals, and students will find in this journal an invaluable resource for enhancing their understanding and staying updated with evolving medical and surgical landscapes. Access options are currently managed through institutional subscriptions, ensuring the dissemination of high-quality research to a diverse audience.

Journal of Egyptian Womens Dermatological Society

Championing Women's Dermatological Wellness and Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1687-1537Frequency: 3 issues/year

The Journal of Egyptian Women's Dermatological Society, published by Wolters Kluwer Medknow Publications, is an essential platform dedicated to advancing the field of dermatology through a valuable focus on women's health issues. Established to provide an open access outlet since 2019, this journal aims to disseminate research, case studies, and reviews that address the unique dermatological needs and concerns of women, particularly in the Egyptian context. Despite its current ranking in the Q4 category in dermatology and a Scopus rank of #117 out of 142 with a 17th percentile, the journal serves a critical role in fostering scholarly communication among researchers, clinicians, and academicians. With a commitment to promoting knowledge advancement and community engagement, this journal invites submissions that align with its objectives, specifically geared towards empirical research and innovative practices in dermatology impacting women's health.

Case Reports in Oncological Medicine

Empowering healthcare professionals with valuable case reports.
Publisher: HINDAWI LTDISSN: 2090-6706Frequency: 1 issue/year

Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.

Cold Spring Harbor Molecular Case Studies

Pioneering new frontiers in biochemistry and genetics.
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2373-2873Frequency: 6 issues/year

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

YONAGO ACTA MEDICA

Exploring Innovations in Medicine and Beyond
Publisher: TOTTORI UNIV MEDICAL PRESSISSN: 0513-5710Frequency: 4 issues/year

YONAGO ACTA MEDICA, published by Tottori University Medical Press, is a prominent journal in the field of Medicine, recognized for its contributions and academic rigor since its inception in 1965. With an ISSN of 0513-5710 and E-ISSN of 1346-8049, this journal is situated in Japan and spans significant periods of convergence from 1965 to 1977 and from 1986 to 2024. Classified within the Q3 category of Medicine (Miscellaneous) and holding a respectable Scopus rank of 275 out of 636 in General Medicine, YONAGO ACTA MEDICA offers an invaluable platform for researchers, professionals, and students to disseminate innovative studies and findings in diverse medical topics. While the journal currently does not operate under an open-access model, it remains committed to promoting academic excellence and advancing medical knowledge through peer-reviewed publications. Address inquiries and contributions to 86 NISHI-CHO, YONAGO, TOTTORI-KEN 683-8503, JAPAN.

Case Reports in Immunology

Fostering Collaboration in Immunology with Every Report
Publisher: HINDAWI LTDISSN: 2090-6609Frequency:

Case Reports in Immunology, published by HINDAWI LTD, is an esteemed open-access journal that has been contributing to the field of immunology since its launch in 2011. With both ISSN 2090-6609 and E-ISSN 2090-6617, the journal provides a platform for researchers to publish detailed case reports that explore diverse immunological conditions and novel treatment approaches. This journal is crucial for clinicians, researchers, and students alike, seeking to broaden their understanding of immunology's practical applications and advances. As of 2023, it holds a Q3 ranking in Immunology and Q2 in Immunology and Allergy, reflecting its growing relevance and contribution to the field. Additionally, it is indexed in Scopus, where it ranks #178 in Immunology and Allergy and #192 in Immunology and Microbiology, enhancing its visibility and impact. With a comprehensive accessibility model, the journal is dedicated to disseminating knowledge widely and enriching discussions in immunological research.

Orphanet Journal of Rare Diseases

Elevating awareness, enhancing lives.
Publisher: BMCISSN: Frequency: 1 issue/year

The Orphanet Journal of Rare Diseases, published by BMC since 2006, serves as a vital platform for the dissemination of groundbreaking research in the realm of rare diseases. With a notable Q1 ranking in both the Medicine (miscellaneous) and Pharmacology (medical) categories, and a respectable Q2 ranking in Genetics (clinical), the journal is recognized for its impactful contributions, evidenced by its position in the top quartiles of Scopus rankings. This open-access journal allows unrestricted access to its content, promoting a global exchange of knowledge among researchers, healthcare professionals, and academics. By covering a broad spectrum of rare diseases, the Orphanet Journal aims to enhance awareness, improve diagnosis and treatment, and ultimately contribute to the improvement of patients' lives. With a commitment to high-quality research, this journal stands as an essential resource for anyone involved in the study or treatment of rare diseases.

International Journal of Clinical and Experimental Pathology

Innovating the Future of Clinical and Experimental Pathology
Publisher: E-CENTURY PUBLISHING CORPISSN: 1936-2625Frequency: 12 issues/year

International Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.

Case Reports in Infectious Diseases

Connecting clinicians with groundbreaking case studies.
Publisher: HINDAWI LTDISSN: 2090-6625Frequency: 1 issue/year

Case Reports in Infectious Diseases is a premier open-access journal published by Hindawi Ltd, dedicated to advancing the field of infectious disease research through the dissemination of case reports that highlight unique clinical presentations, innovative treatment approaches, and novel diagnostic techniques. Since its inception in 2011, this journal has provided a vital platform for healthcare professionals, academicians, and researchers to share their findings, thereby enhancing the collective understanding of infectious diseases. Featuring a diverse range of case studies, the journal aims to inspire further research and clinical inquiry, making it an invaluable resource for anyone involved in the fight against infectious diseases. With an easily accessible online format, it caters to a global audience, ensuring that critical insights are available to all stakeholders in this crucial field.

Journal of Cardiovascular Translational Research

Empowering Researchers to Revolutionize Cardiovascular Care
Publisher: SPRINGERISSN: 1937-5387Frequency: 6 issues/year

Journal of Cardiovascular Translational Research, published by Springer, is a pivotal platform in the fields of cardiology, genetics, and molecular medicine, dedicated to bridging the gap between experimental research and clinical application. With an impressive impact factor and a robust ranking—such as Rank #84/387 in Cardiology and Cardiovascular Medicine—this journal offers valuable insights and innovative research vital for understanding cardiovascular diseases and their implications. The journal spans a unique converged spectrum of topics, encompassing pharmaceutical sciences and genetic advancements, making it an essential resource for researchers, healthcare professionals, and students alike, striving for excellence in cardiovascular health. Although not open access, the journal ensures that cutting-edge research from 2008 to 2024 is readily available for a diverse readership eager to harness knowledge for clinical progress and improved patient outcomes.